Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

1.3K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.3K
Preclinical Development: Overview01:28

Preclinical Development: Overview

4.5K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.5K
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

5.6K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.6K
Clinical Trials: Overview01:11

Clinical Trials: Overview

3.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.0K
Drug Regulation01:25

Drug Regulation

1.4K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.4K
Drug Discovery: Overview01:26

Drug Discovery: Overview

8.0K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.0K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Harlequin syndrome: segmental autonomic dysfunction in the realm of Sjogren's disease.

Rheumatology (Oxford, England)·2026
Same author

Unifying theories in high-dimensional biophysics: approaches, challenges and opportunities.

NPJ systems biology and applications·2026
Same author

Hypertension Management Beyond Blood Pressure Control in India: An Expert Consensus on Angiotensin II Receptor Blocker and Calcium Channel Blocker Combination Therapy With Reference to Telmisartan and Cilnidipine.

Cureus·2026
Same author

Host-directed treatments for tuberculous meningitis: A multi-platform approach across mouse and human models.

Research square·2026
Same author

Shared multicellular injury programs of acute and chronic kidney disease enable mechanistic patient stratification.

medRxiv : the preprint server for health sciences·2026
Same author

Invasive mould infections of the central nervous system in the Indian population: a cohort study (2004-2025).

The Lancet regional health. Southeast Asia·2026

相关实验视频

Updated: Jul 12, 2025

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
09:19

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

8.7K

药物开发中的致癌性测试:正确执行

Paul Baldrick1, Sanjay Jain1

  • 1Product Development and Market Access Consulting, Fortrea, 5 Foundation Park, Roxborough Way, Maidenhead, SL6 3UD, United Kingdom(1).

Regulatory toxicology and pharmacology : RTP
|October 25, 2023
PubMed
概括
此摘要是机器生成的。

在动物中进行的药物致癌性测试为人类的风险评估提供了信息. 监管互动,比如美国食品和药物管理局.

关键词:
致癌性 致癌性 致癌性剂量水平选择选择剂量水平选择鼠标 鼠标是一个鼠标.鼠标 鼠标 鼠标 鼠标监管机构 监管机构转基因小鼠转基因小鼠

更多相关视频

Advanced 3D Liver Models for In vitro Genotoxicity Testing Following Long-Term Nanomaterial Exposure
08:25

Advanced 3D Liver Models for In vitro Genotoxicity Testing Following Long-Term Nanomaterial Exposure

Published on: June 5, 2020

6.8K
Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate DMBA-TPA
04:12

Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate DMBA-TPA

Published on: December 19, 2019

14.4K

相关实验视频

Last Updated: Jul 12, 2025

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
09:19

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

8.7K
Advanced 3D Liver Models for In vitro Genotoxicity Testing Following Long-Term Nanomaterial Exposure
08:25

Advanced 3D Liver Models for In vitro Genotoxicity Testing Following Long-Term Nanomaterial Exposure

Published on: June 5, 2020

6.8K
Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate DMBA-TPA
04:12

Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate DMBA-TPA

Published on: December 19, 2019

14.4K

科学领域:

  • 监管科学是一种监管科学.
  • 毒理学 毒理学 毒理学
  • 制药发展 制药发展

背景情况:

  • 在动物中进行致癌性测试对于评估药物药物对人类的风险至关重要.
  • 标准测试包括2年的动物研究或6个月的转基因小鼠研究.
  • 监管参与,例如美国FDA的特别协议评估 (SPA),是协议批准的关键.

研究的目的:

  • 检查有关制药致癌性测试协议的监管相互作用.
  • 分析机构参与的结果,重点是剂量选择和研究设计.
  • 评估药物批准当前监管流程的有效性.

主要方法:

  • 分析了向致癌性评估委员会 (CAC) 提交的37份报告.
  • 检查监管相互作用,包括FDA的特别协议评估 (SPA) 过程.
  • 审查研究设计方面:动物数量,对照组和毒动力学 (TK) 评估.

主要成果:

  • 目前的监管互动过程通常会产生可接受的致癌性研究来批准药物.
  • 分析揭示了在提交内容和研究设计方面需要改进的具体领域.
  • 关键结果包括对研究剂量水平选择和协议元素的洞察.

结论:

  • 现有的监管框架支持开发可接受的致癌性研究,用于药物营销.
  • 有机会提高提交文件的质量和致癌性研究的设计.
  • 监管互动的持续改进可以进一步优化药物开发和批准过程.